127 related articles for article (PubMed ID: 6281386)
21. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
Bhargava HN; Gulati A
Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
[TBL] [Abstract][Full Text] [Related]
22. TRH receptor binding in avian pituitary and brain.
Thompson DF; Taylor RL; Burt DR
Gen Comp Endocrinol; 1981 May; 44(1):77-81. PubMed ID: 6263748
[No Abstract] [Full Text] [Related]
23. Guanine nucleotide regulation of receptor binding of thyrotropin-releasing hormone (TRH) in rat brain regions, retina and pituitary.
Sharif NA; Burt DR
Neurosci Lett; 1987 Oct; 81(3):339-44. PubMed ID: 2829061
[TBL] [Abstract][Full Text] [Related]
24. Central and peripheral type benzodiazepine ligands displace [3H][3-ME-HIS2]TRH from its binding sites in the brain and the anterior pituitary and antagonize the effect of TRH in the rat duodenum.
Järvinen A; Paakkari I; Männistö PT
Neuropeptides; 1991 Jul; 19(3):147-55. PubMed ID: 1654530
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
26. Limbic, hypothalamic, cortical and spinal regions are enriched in receptors for thyrotropin-releasing hormone: evidence from [3H]ultrofilm autoradiography and correlation with central effects of the tripeptide in rat brain.
Sharif NA; Burt DR
Neurosci Lett; 1985 Oct; 60(3):337-42. PubMed ID: 2999650
[TBL] [Abstract][Full Text] [Related]
27. Thyrotropin releasing hormone (TRH) binding sites in the adult human brain: localization and characterization.
Parker CR; Capdevila A
Peptides; 1984; 5(4):701-6. PubMed ID: 6093073
[TBL] [Abstract][Full Text] [Related]
28. Biochemical and autoradiographic studies of TRH receptors in sections of rabbit spinal cord.
Sharif NA; Pilotte NS; Burt DR
Biochem Biophys Res Commun; 1983 Oct; 116(2):669-74. PubMed ID: 6316961
[TBL] [Abstract][Full Text] [Related]
29. Micromolar substance P reduces spinal receptor binding for thyrotropin-releasing hormone--possible relevance to neuropeptide coexistence?
Sharif NA; Burt DR
Neurosci Lett; 1983 Dec; 43(2-3):245-51. PubMed ID: 6200806
[TBL] [Abstract][Full Text] [Related]
30. Differential affinities of TRH analogs at the mammalian spinal cord TRH receptor: implications for therapy in spinal injuries.
Sharif NA; To Z; Michel AD; Whiting RL
Neurosci Lett; 1989 Sep; 104(1-2):183-8. PubMed ID: 2554219
[TBL] [Abstract][Full Text] [Related]
31. Various types of thyrotropin-releasing hormone receptors in discrete brain regions and the pituitary of the rat.
Funatsu K; Teshima S; Inanaga K
J Neurochem; 1985 Aug; 45(2):390-7. PubMed ID: 2989427
[TBL] [Abstract][Full Text] [Related]
32. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
Bhargava HN; Das S; Bansinath M; Prasad R
Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
[TBL] [Abstract][Full Text] [Related]
33. Binding of TRH, DN-1417 and MK-771 to TRH receptors in the rat brain. Relationship to their central actions.
Funatsu K; Teshima S; Inanaga K
Kurume Med J; 1983; 30 Suppl():S45-50. PubMed ID: 6090771
[No Abstract] [Full Text] [Related]
34. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue.
Urayama A; Yamada S; Deguchi Y; Kimura R; Maeda Y; Kobayashi T
Life Sci; 1999; 65(22):2407-15. PubMed ID: 10597895
[TBL] [Abstract][Full Text] [Related]
35. Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systems.
Sharif NA
J Neurochem; 1988 Feb; 50(2):388-94. PubMed ID: 2826693
[TBL] [Abstract][Full Text] [Related]
36. TRH analogue with C-terminal thioamide group. Synthesis, receptor binding, TSH-releasing activity and alpha-MSH-releasing activity.
Kruszyński M; Kupryszewski G; Ragnarsson U; Alexandrova M; Strbak V; Tonon MC; Vaudry H
Experientia; 1985 Dec; 41(12):1576-7. PubMed ID: 3000815
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of thyrotropin releasing hormone (TRH) receptors in rat brain.
Ogawa N; Yamawaki Y; Kuroda H; Nukina I; Ota Z; Fujino M; Yanaihara N
Peptides; 1982; 3(4):669-77. PubMed ID: 6291012
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologically distinct binding sites in rat brain for [3H]thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine(2)]TRH.
Kelly JA; Slator GR; O'Boyle KM
Biochem Pharmacol; 2002 Jun; 63(12):2197-206. PubMed ID: 12110379
[TBL] [Abstract][Full Text] [Related]
39. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects.
Angyal R; Strbák V; Alexandrová M; Kruszyński M
Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750
[TBL] [Abstract][Full Text] [Related]
40. Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects.
Sharif NA; Burt DR
Regul Pept; 1983 Dec; 7(4):399-411. PubMed ID: 6322242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
